avapro has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, V; Dalman, RL; Hezi-Yamit, A; Iida, Y; Peterson, SR; Schultz, GM; Sulaimon, S; White, JJ; Xu, B | 1 |
1 other study(ies) available for avapro and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Benzimidazoles; Benzoates; Biphenyl Compounds; Bosentan; Doxycycline; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Sulfonamides; Telmisartan; Tetrazoles | 2012 |